09.10.2008 20:03:00

Invitrogen Joins EPA's Climate Leaders Program

As a part of its continued commitment to environmental sustainability, Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced its participation in the U.S. Environmental Protection Agencys (EPAs) Climate Leaders program. By participating in Climate Leaders, Invitrogen has pledged to reduce its corporate-wide greenhouse gas emissions.

Climate Leaders is an EPA industry-government partnership that works with companies to develop comprehensive climate change strategies. Partner companies commit to reducing their impact on the global environment by completing a corporate-wide inventory of their greenhouse gas emissions based on a quality management system, setting aggressive reduction goals, and annually reporting their progress to EPA. Through program participation, companies create a credible record of their accomplishments and receive EPA recognition as corporate environmental leaders.

"EPA applauds our corporate partners who are reducing their climate footprints in cost-effective ways, said EPA Administrator Stephen L. Johnson. "Not only is Invitrogen contributing to this countrys energy independence, the company is proving that businesses can save green by going green.

Invitrogen is already demonstrating corporate climate change leadership by embracing reduction of its CO2 emissions by focusing on energy conservation and efficiency, alternative sources of energy, LEED certification of its buildings, and technological innovation.

"Addressing climate change is a key part of Invitrogens corporate responsibility, said Cristina Amorim, Invitrogens Sr. Director of Global Environmental Health and Safety. "With the implementation of a number of energy conservation projects, Invitrogen has already decreased our carbon dioxide emissions by 35 percent since 2004.

Invitrogen is active in other worldwide environmental sustainability programs in addition to the EPAs Climate Leaders program. These include:

  • In Carlsbad, Calif., more than 26 tons of electrical equipment waste has been recycled, preventing it from filling landfills in 2007.
  • In Norway, cogeneration transforms waste into energyevery year, 840 tons of flammable hazardous waste is burned, generating heat energy for offices.
  • In Frederick, Md., Invitrogen reduced one of its hazardous waste streams in the manufacturing area by 96% in 2007.
  • In Inchinnan, United Kingdom, the site implemented smart processes, saving 14,000 cubic meters of water per year, recycling 40 tons of cardboard and paper per year and preventing 170 tons/year of bottled liquid waste from being disposed in landfills.

For more information about Invitrogens corporate environmental responsibility programs, click here. For more information about Climate Leaders, visit http://www.epa.gov/climateleaders.

About Invitrogen

Invitrogen Corporation (NASDAQ:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of approximately $1.3 billion in 2007. For more information, visit www.invitrogen.com.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Invitrogen Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Invitrogen Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 218,17 0,83%
NASDAQ 100 20 930,37 0,90%
S&P 400 MidCap 1 854,40 -0,45%